Responses
Pancreatic tract
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis
Compose a Response to This Article
Other responses
No responses have been published for this article.